BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Pharma QC

EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement

In this alliance, MTPC and EditForce aim to create potential novel pharmaceuticals for the specific CNS disease by utilizing the drug R&D know-how and ...

July 06, 2022 | News

New Shanghai office expands APAC operations for Eurofins DiscoverX.

The launch of Eurofins DiscoverX (Shanghai) Ltd. broadens its Asia-Pacific operations directly into the China market. This expansion es...

June 30, 2022 | News

Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies

Palleon Pharmaceuticals Inc., a company pioneering the field of glyco-immunology to treat cancer and inflammatory diseases, today announced a str...

June 29, 2022 | News

Antengene Announces Clinical Trial Collaboration with BeiGene

Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor Antengene Corporation Limited ("...

June 27, 2022 | News

Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

June 24, 2022 | News

Merck Announces Collaboration with Agilent Technologies to Fill Industry Gap in Process Analytical Technologies for Downstream Processing

Merck, a leading science and technology company, today announced that it has entered a collaboration with Agilent Technologies to advance Process Analytica...

June 16, 2022 | News

Thermo Fisher Scientific Announces Cross-Industry Collaboration

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, is showcasing new instruments, workflows, software and industry collaborat...

June 06, 2022 | News

ProBioGen Grows by 50 Percent in Last Two Years

The Berlin-based biopharmaceutical enterprise ProBioGen has increased its staff by 50 percent since April 2020. More than 250 "ProBioGeniuses", a...

June 03, 2022 | News

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific

"Stability storage and testing is a critical component of drug development and commercialization of new therapies. Q1 Scientific brings world-class capabil...

June 02, 2022 | News

Medison Pharma strengthening its commercial offering into Australia and New Zealand

Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international mark...

May 24, 2022 | News

Croda announces the new Pharma business

Croda Pharma has seen exceptional growth across its high purity excipients and vaccine adjuvants area and more recently announced the acquisition of Avanti...

May 19, 2022 | News

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

The 2022 CSCO Guidelines incorporate a total of four selinexor combination therapy regimens for relapsed myeloma. In addition, the guidelines also recommen...

May 13, 2022 | News

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies an...

May 11, 2022 | News

TIKOMED and IQVIA announce a strategic collaboration

Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead ...

May 06, 2022 | News

Stay Connected